Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: Clozapine-related Immunodeficiency in Parkinsons Disease [Phase 4]

View source ↗

Summary

A phase 4 clinical trial is investigating clozapine-related immunodeficiency in Parkinson's disease and is currently recruiting. The study is sponsored by Centr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Clozapine, Parkinson's Disease (PD) | Phase 4 | Status: RECRUITING